IL143296A0 - Use of human prostate cell lines in cancer treatment - Google Patents

Use of human prostate cell lines in cancer treatment

Info

Publication number
IL143296A0
IL143296A0 IL14329699A IL14329699A IL143296A0 IL 143296 A0 IL143296 A0 IL 143296A0 IL 14329699 A IL14329699 A IL 14329699A IL 14329699 A IL14329699 A IL 14329699A IL 143296 A0 IL143296 A0 IL 143296A0
Authority
IL
Israel
Prior art keywords
cell lines
cancer treatment
human prostate
prostate cell
derivatives
Prior art date
Application number
IL14329699A
Other languages
English (en)
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Publication of IL143296A0 publication Critical patent/IL143296A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL14329699A 1998-12-10 1999-12-09 Use of human prostate cell lines in cancer treatment IL143296A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827104.2A GB9827104D0 (en) 1998-12-10 1998-12-10 New cancer treatments
PCT/GB1999/004129 WO2000033869A2 (en) 1998-12-10 1999-12-09 Use of human prostrate cell lines in cancer treatment

Publications (1)

Publication Number Publication Date
IL143296A0 true IL143296A0 (en) 2002-04-21

Family

ID=10843926

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14329699A IL143296A0 (en) 1998-12-10 1999-12-09 Use of human prostate cell lines in cancer treatment
IL143296A IL143296A (en) 1998-12-10 2001-05-22 Factor containing a line of prostate cells, preparations containing it and use in the treatment of prostate cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143296A IL143296A (en) 1998-12-10 2001-05-22 Factor containing a line of prostate cells, preparations containing it and use in the treatment of prostate cancer

Country Status (19)

Country Link
US (3) US6972128B1 (hu)
EP (1) EP1137422B1 (hu)
JP (2) JP4949554B2 (hu)
KR (1) KR20010090874A (hu)
AT (1) ATE304365T1 (hu)
AU (1) AU763485B2 (hu)
CA (1) CA2354045C (hu)
CZ (1) CZ300499B6 (hu)
DE (1) DE69927286T2 (hu)
ES (1) ES2249046T3 (hu)
GB (1) GB9827104D0 (hu)
HU (1) HUP0104568A3 (hu)
IL (2) IL143296A0 (hu)
MX (1) MXPA01005816A (hu)
NO (1) NO327044B1 (hu)
NZ (1) NZ512004A (hu)
PL (1) PL201016B1 (hu)
WO (1) WO2000033869A2 (hu)
ZA (1) ZA200104164B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
WO2000071156A2 (en) * 1999-05-21 2000-11-30 Onyvax Limited New vaccine formulations-3
WO2001075073A2 (en) * 2000-04-01 2001-10-11 Onyvax Limited Prostate cell lines and their use
US6667479B2 (en) * 2001-06-01 2003-12-23 Raytheon Company Advanced high speed, multi-level uncooled bolometer and method for fabricating same
US20050019336A1 (en) * 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
MXPA06002159A (es) * 2003-08-26 2006-05-22 Becton Dickinson Co Metodos para la administracion intradermica de agentes terapeuticos.
EP2127671B1 (en) * 2007-02-07 2016-09-14 Nec Corporation Therapeutic agent for cancer
WO2009066462A1 (ja) * 2007-11-20 2009-05-28 Nec Corporation 細胞傷害性ｔ細胞の誘導方法、細胞傷害性ｔ細胞の誘導剤、およびそれを用いた医薬組成物およびワクチン
AU2009200767A1 (en) * 2008-03-10 2009-09-24 Aristocrat Technologies Australia Pty Limited A gaming system and a method of gaming
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69232890T2 (de) * 1991-10-04 2003-10-09 Whitehead Biomedical Inst Regulierung der systemischen immunantworten mittels zytokinen und antigenen
JPH05246889A (ja) * 1992-03-05 1993-09-24 Seitai Chiyousetsu Kenkyusho:Kk 制癌方法および制癌剤
AU2370195A (en) * 1994-04-28 1995-11-29 Scott Freeman Cell lines obtained by (in vivo) migration and by fusion with autoimmune cells
US5837233A (en) * 1995-03-17 1998-11-17 University Of California Method for treating tumors
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
ES2191784T3 (es) * 1995-12-28 2003-09-16 Univ Johns Hopkins Med Vacunas de tumores de citocinas paracrinas alogenicas.
CA2245099C (en) * 1996-02-02 2007-01-09 Suzanne L. Topalian Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
GB9620350D0 (en) * 1996-09-30 1996-11-13 Maudsley David J Cancer vaccine
US6207805B1 (en) * 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments

Also Published As

Publication number Publication date
CA2354045A1 (en) 2000-06-15
PL348828A1 (en) 2002-06-17
PL201016B1 (pl) 2009-02-27
ES2249046T3 (es) 2006-03-16
WO2000033869A3 (en) 2000-10-12
NO20012634D0 (no) 2001-05-29
JP2012021028A (ja) 2012-02-02
NO20012634L (no) 2001-08-08
JP4949554B2 (ja) 2012-06-13
KR20010090874A (ko) 2001-10-19
CZ20012032A3 (cs) 2001-10-17
US6972128B1 (en) 2005-12-06
CZ300499B6 (cs) 2009-06-03
DE69927286T2 (de) 2006-06-29
US20120164099A1 (en) 2012-06-28
HUP0104568A2 (hu) 2002-03-28
DE69927286D1 (de) 2005-10-20
GB9827104D0 (en) 1999-02-03
MXPA01005816A (es) 2002-03-27
EP1137422A2 (en) 2001-10-04
AU763485B2 (en) 2003-07-24
NO327044B1 (no) 2009-04-06
EP1137422B1 (en) 2005-09-14
IL143296A (en) 2006-06-11
NZ512004A (en) 2003-08-29
ATE304365T1 (de) 2005-09-15
US20050249756A1 (en) 2005-11-10
JP2002531520A (ja) 2002-09-24
HUP0104568A3 (en) 2004-05-28
US8034360B2 (en) 2011-10-11
ZA200104164B (en) 2002-01-24
WO2000033869A2 (en) 2000-06-15
CA2354045C (en) 2012-02-21
AU1668300A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
GEP20094798B (en) (s,s)-reboxetine for treating chronic pain
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
EP1381280A4 (en) VIRAL VECTORS AND USE THEREOF IN THERAPEUTIC METHODS
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
IL143296A0 (en) Use of human prostate cell lines in cancer treatment
MXPA04006572A (es) Terapia de combinacion antivirica.
PT967987E (pt) Composicoes para o tratamento de tumores contendo extractos de cartilagem de tubarao e agentes antineoplasicos
WO2002066044A3 (en) Method for dendritic cells based immunotherapy of tumors using combination therapy
ZA200003236B (en) Combination therapy for the treatment of migraine.
AU6083301A (en) Treating eczema and/or psoriasis
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
IL131478A0 (en) Methods for treatment of scar tissue
PL1827403T3 (pl) Kompozycje do leczenia stanów patologicznych powierzchni oka
ZA200002338B (en) Combination therapy for the treatment of migraine.
ZA200003235B (en) Combination therapy for the treatment of migraine.
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
ES2169986A1 (es) Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.
HK1048263A1 (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides.
ZA200002343B (en) Combination therapy for the treatment of migraine.
AU5434899A (en) Cancer treatment
MXPA02000485A (es) 2-amino-benzoxazinonas para el tratamiento del virus de herpes simple.
UA33359A (uk) Спосіб доступу до пухлин орбіти
ES2183734A1 (es) Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed